“Prospective Study on Low-Dose Mifepristone for the Treatment of Leiomyoma: A Hospital Based Study”, Int. Arch. Biomed. Clin. Res., vol. 4, no. 1, pp. 104–106, Apr. 2024, doi: 10.21276/6jye9820.